Satovsky Asset Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2,522
Closed -$219K 75
2026
Q1
$219K Buy
2,522
+150
+6% +$14.4K 0.04% 69
2025
Q4
$228K Buy
2,372
+55
+2% +$5.34K 0.04% 65
2025
Q3
$221K Buy
2,317
+16
+0.7% +$1.47K 0.04% 60
2025
Q2
$201K Buy
2,301
+17
+0.7% +$1.44K 0.04% 62
2025
Q1
$205K Buy
+2,284
New +$204K 0.05% 53
2024
Q4
Sell
-2,264
Closed -$204K 55
2024
Q3
$204K Buy
+2,264
New +$190K 0.05% 54
2022
Q2
Sell
-1,953
Closed -$217K 38
2022
Q1
$217K Buy
+1,953
New +$206K 0.15% 31
2021
Q4
Sell
-1,734
Closed -$217K 33
2021
Q3
$217K Buy
1,734
+9
+0.5% +$1.17K 0.16% 26
2021
Q2
$214K Buy
1,725
+8
+0.5% +$1K 0.16% 28
2021
Q1
$203K Buy
1,717
+9
+0.5% +$1.05K 0.18% 27
2020
Q4
$200K Buy
+1,708
New +$188K 0.19% 25

Other funds holding MDT

Satovsky Asset Management's MDT Position: Q2 2026 in Review

Satovsky Asset Management sold out of Medtronic (MDT) in Q2 2026, closing a stake of 2,522 shares — an estimated $219K sold.

Satovsky Asset Management first reported a position in MDT in Q4 2020 and held it in 11 quarters. The position peaked at $228K in Q4 2025. 2,134 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Satovsky Asset Management reported no remaining Medtronic position as of Q2 2026 after selling out during the quarter.
  • Satovsky Asset Management sold 2,522 Medtronic shares in Q2 2026, an estimated $219K.
  • Satovsky Asset Management first reported a position in Medtronic in Q4 2020 and held it in 11 quarters.
  • Satovsky Asset Management's Medtronic position peaked at $228K in Q4 2025.
  • 2,134 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Satovsky Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.